Does Mounjaro have a $25 coupon available?
Yes, some insurance companies may cover your prescription for Mounjaro, but this will vary based on your insurance plan and drug benefits. Your insurance company may cover Mounjaro for type 2 diabetes, but may not cover Mounjaro for weight loss. To find out if your drug plan will pay for Mounjaro, contact your drug benefit company and ask if Mounjaro is on their formulary, and which conditions it covers.
Mounjaro $25 Coupon
Eli Lilly the manufacturer of Mounjaro offers a $25 coupon that can lower your cost to $25 for up to a 3-month supply, if you have commercial prescription insurance and a documented diagnosis of type 2 diabetes. Patients covered under government insurance such as Medicare or Medicaid do not qualify for the $25 savings card.
Click here for coupon link: Mounjaro Price Guide and Savings Coupons
The amount you pay for Mounjaro will depend upon your prescription drug coverage, deductible and copay (determined by the “tier”). Higher tiers, like tier 3 or 4, usually mean higher copays. If you have not fully met your yearly deductible, or if the drug is not covered, you may be responsible for the full monthly cost of this drug, which may be over $900. Coverages will vary among plans.
How do I get the Mounjaro savings card?
Eli Lilly, the manufacturer of Mounjaro offers a savings card program for eligible patients with commercial prescription drug insurance, even if your insurance plan does not cover Mounjaro. You may pay as little as $25 for up to a 3-month prescription (up to 12 pens).
Commercial insurance is the type often offered through your employer or bought through the Marketplace at Healthcare.gov.
If you have type 2 diabetes and are an adult resident of the U.S., you may be able to save money with Mounjaro by using this savings card. You can obtain and activate the savings card on the Mounjaro website before you use it, or you can call Eli Lilly at 1-844-805-5807.
If you do not have prescription insurance or you have government-sponsored insurance (such as Medicare, Medicaid, Medicare Part D, Medigap, DoD, VA, TriCare/Champus, or any state or pharmaceutical assistance program), you are not eligible for the $25 Mounjaro prescription drug savings card.
How long does the Mounjaro savings card last?
If your insurance covers Mounjaro and you are eligible, you can use the Mounjaro savings card until Dec. 31, 2023 OR for up to 24, one-month fills (4 pens each fill), whichever comes first.
If you have commercial prescription insurance and are eligible, but your insurance does NOT cover Mounjaro, this offer is good until June 30, 2023 for up to 12 one-month fills (4 pens each fill), whichever comes first.
The total insurance drug cost picked up by the manufacturer for the savings card program is a maximum of $250 or $500 per month and a separate annual cap of $3,000. You are responsible for any costs that exceed the monthly or annual costs.
If you do not have commercial insurance, but need assistance, you can call The Lilly Answers Center (TLAC) at 1-800-LillyRx (1-800-545-5979) for additional information on other types of payment options.
When will insurance pay for Mounjaro?
If your insurance pays for Mounjaro, it will typically only be paid for when it is prescribed for its FDA approved indication, type 2 diabetes.
Mounjaro is not yet approved as a weight loss medication, and insurance companies will not typically cover any cost for this use, even if your doctor writes you a prescription for weight loss (known as an “off-label” indication).
Studies are ongoing for the Mounjaro approval for weight-loss, and results show it is very effective. Mounjaro (tirzepatide) has led to about 21% to 22.5% weight loss at the highest dose, in investigational clinical trials for weight management. These numbers approach what is seen with bariatric (weight loss) surgery.
Other FDA-approved options similar to Mounjaro are available for use in weight loss. Wegovy (generic name: semaglutide) is an FDA-approved for the weight loss that is similar to, but not exactly the same as Mounjaro. Semaglutide is also sold under the brand names Ozempic and Rybelsus for type 2 diabetes in the U.S.
How do I get insurance to cover Mounjaro?
If your doctor agrees Mounjaro is right for you, and your insurance pays for Mounjaro, you may have to follow a “stepped therapy” plan for type 2 diabetes treatment before you are eligible for coverage. The specifics for these plans may vary among insurance companies.
Your doctor may need to fill out a “prior authorization” form, which is paperwork submitted to the insurance company to determine your eligibility for Mounjaro. It can take several days or longer to hear the decision.
Drug plans may require you to have previously had an inadequate response to several different types of 2 diabetes treatments (called “stepped therapy”), or experienced intolerable side effects, before you are eligible for Mounjaro treatment.
How much does one month of Mounjaro cost?
The list price for Mounjaro is about $974 for a one month (28-day) supply of Mounjaro (equal to four pens) as of December 2022, but most people do not pay this price. The price you pay is dependent on your insurance coverage, deductibles and copays. The manufacturer may be able to offer a $25 savings card or patient financial assistance, if you qualify.
Pricing for specific insurance plans is not yet available, according to Eli Lilly, the manufacturer of Mounjaro. Eli Lilly has stated they will share the average out-of-pocket costs for patients once they become available in 2023.
Which insurance covers Mounjaro?
Your prescription drug insurance company can tell you if Mounjaro is covered under your plan. Call your insurance and ask if Mounjaro is on their formulary, and which conditions it covers. You can usually find the number to call on the back of your card.
Eli Lilly, the manufacturer of Mounjaro offers a copay card program for patients with commercial prescription drug insurance who qualify, even if their insurance plan does not cover Mounjaro. You may pay as little as $25 for up to a 3-month supply. Contact the Mounjaro patient services support center at 844-805-5807 to learn more.
In general, government programs like Medicare Part D prescription drug plans and state Medicaid plans do not cover the cost of Mounjaro at this time, but an accepted prior authorization may allow coverage for the patient.
Is Mounjaro available as a generic?
No, Mounjaro (generic name: tirzepatide) was first approved in 2022 and a generic option is not expected before 2036.
Mounjaro is an expensive injectable medicine used weekly to help lower blood sugar levels in adults with type 2 diabetes, but a copay card may help to lower your costs, if you have commercial drug insurance.
This is not all the information you need to know about Mounjaro (tirzepatide) for safe and effective use and does not take the place of your doctor’s directions. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.
What is Mounjaro?
Mounjaro (tirzepatide) is a new medicine approved by the FDA in May 2022 to help lower blood sugar in adult patients with type 2 diabetes. It is used in addition to a weight-loss diet and exercise. Mounjaro is not yet approved as a weight loss medication, but it may help you lose weight if you have type 2 diabetes. It is given as a weekly subcutaneous (under the skin) injection. You can learn to administer this medicine for home use.
Related medical questions
- Does Mounjaro have a $25 coupon available?
- How does Mounjaro work for weight loss? How much will I lose?
- How do Ozempic, Mounjaro, Wegovy, Zepbound compare for weight loss?
- Can you get tirzepatide from a compounding pharmacy?
- How much weight can I lose on Zepbound?
- How do you use Zepbound?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions